Diphtheria, Tetanus, and Pertussis
Journal: Annals of Internal Medicine (1981)

Diagnosis and Treatment1 December 1981Diphtheria, Tetanus, and PertussisGuidelines for Vaccine Prophylaxis and Other Preventive MeasuresAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-95-6-723 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractThis statement is a revision of the 1977 statement from the Immunization Practices Advisory Committee, Centers for Disease Control, on diphtheria, tetanus, and pertussis. The epidemiology of these diseases, a description of the available immunobiologic preparations, the appropriate immunization schedules, and precautions or contraindications to vaccine use are reviewed. No major changes in immunization policy are recommended.Selected Bibliography DIPHTHERIA TETANUS PERTUSSIS1. BELSEY M, SINCLAIR M, RODER M, and LEBLANC D. Corynebacterium diphtheriae skin infections in Alabama and Louisiana: a factor in the epidemiology of diphtheria. N Engl J Med. 1969;280:135-41. CrossrefMedlineGoogle Scholar2. . Diphtheria Surveillance Report no. 12, 1971-1975 Summary. July 1978. Google Scholar3. BROWN G, VOLK V, GOTTSHALL R, KENDRICK P, and ANDERSON H. Responses of infants to DTP-P vaccine used in nine injection schedules. Public Health Rep. 1964;79:585-602. CrossrefMedlineGoogle Scholar4. DOULL J. Factors influencing selective distribution in diphtheria. J Prev Med. 1930;4:371-404. Google Scholar5. EDSALL G, ALTMAN J, and GASPAR A. Combined tetanus-diphtheria immunization of adults: use of small doses of diphtheria toxoid. Am J Public Health. 1954;44:1537-45. CrossrefGoogle Scholar6. IPSEN J. Circulating antitoxin at onset of diphtheria in 425 patients. J Immunol. 1946;54:325-47. CrossrefMedlineGoogle Scholar7. GOTTLIEB S, MARTIN M, MCLAUGHLIN F, PANARO R, LEVINE L, and EDSALL G. Long-term immunity to diphtheria and tetanus: a mathematical model. Am J Epidemiol. 1967;85:207-19. CrossrefMedlineGoogle Scholar8. KOOPMAN J and CAMPBELL J. The role of cutaneous diphtheria infections in a diphtheria epidemic. J Infect Dis. 1975;131:239-44. CrossrefMedlineGoogle Scholar9. NAIDITCH M and BOWER A. Diphtheria: a study of 1,433 cases observed during 10-year period at Los Angeles County Hospital. Am J Med. 1954;17:229-45. CrossrefMedlineGoogle Scholar10. SCHEIBEL I, BENTZON M, CHRISTENSEN P, and BIERING A. Duration of immunity to diphtheria and tetanus after active immunization. Acta Pathol Microbiol Scand. 1966;67:380-92. CrossrefMedlineGoogle Scholar11. TASMAN A and LANSBERG H. Problems concerning the prophylaxis, pathogenesis, and therapy of diphtheria. Bull WHO. 1957;16:939-73. MedlineGoogle Scholar12. VOLK V, GOTTSHALL R, ANDERSON H, TOP F, BUNNEY W, and SERFLING R. Antigenic responses to booster dose of diphtheria and tetanus toxoids. Seven to thirteen years after primary inoculation of noninstitutionalized children. Public Health Rep. 1962;77:185-94. CrossrefMedlineGoogle Scholar13. BLUMSTEIN G and KREITHEN H. Peripheral neuropathy following tetanus toxoid administration. JAMA. 1966;198:1030-1. CrossrefMedlineGoogle Scholar14. BROWN G, VOLK V, GOTTSHALL R, KENDRICK P, and ANDERSON H. Responses of infants to DTP-P vaccine used in nine injection schedules. Public Health Rep. 1964;79:585-602. CrossrefMedlineGoogle Scholar15. . Tetanus Surveillance Report no. 4, 1970-1971 Summary. 31 March 1974. Google Scholar16. ECKMANN L, ed. Principles on Tetanus: Proceedings of the International Conference on Tetanus, 2nd. Bern, 1966. Bern: Huber; 1967. Google Scholar17. EDSALL G. Specific prophylaxis of tetanus. JAMA. 1959;171:417-27. CrossrefMedlineGoogle Scholar18. EDSALL G, ELLIOTT M, PEEBLES T, LEVINE L, and ELDRED M. Excessive use of tetanus toxoid boosters. JAMA. 1967;202:17-9. CrossrefGoogle Scholar19. GOTTLIEB S, MARTIN M, MCLAUGHLIN F, PANARO R, LEVINE L, and EDSALL G. Long-term immunity to diphtheria and tetanus: a mathematical model. Am J Epidemiol. 1967;85:207-19. CrossrefMedlineGoogle Scholar20. LAFORCE F, YOUNG L, and BENNETT J. Tetanus in the United States (1965-1966): epidemiologic and clinical features. N Engl J Med. 1969;280:569-74. CrossrefMedlineGoogle Scholar21. MACLENNAN R, SCHOFIELD F, PITTMAN M, HARDEGREE M, and BARILE M. Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids. Bull WHO. 1965;32:683-97. MedlineGoogle Scholar22. PEEBLES T, LEVINE L, ELDRED M, and EDSALL G. Tetanus-toxoid emergency boosters: a reappraisal. N Engl J Med. 1969;280:575-81. CrossrefMedlineGoogle Scholar23. SCHEIBEL I, BENTZON M, CHRISTENSEN P, and BEIRING A. Duration of immunity to diphtheria and tetanus after active immunization. Acta Pathol Microbiol Scand. 1966;67:380-92. CrossrefMedlineGoogle Scholar24. SURI J, DHILLON H, and GREWAL H. Active immunization of women in pregnancy for prevention of neonatal tetanus. Bull WHO. 1964;31:349-57. MedlineGoogle Scholar25. VOLK V, GOTTSHALL R, ANDERSON H, TOP F, BUNNEY W, and SERFLING R. Antigenic response to booster dose of diphtheria and tetanus toxoids. Seven to thirteen years after primary inoculation of noninstitutionalized children. Public Health Rep. 1962;77:185-94. CrossrefMedlineGoogle Scholar26. WHITE W, BARNES G, GRIFFITH A, GALL D, BARKER E, and SMITH J. Duration of immunity after active immunization against tetanus. Lancet. 1969;2:95-6. CrossrefMedlineGoogle Scholar27. BARAFF L, WILKINS J, and WEHRLE P. The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics. 1978;61:224-30. CrossrefMedlineGoogle Scholar28. BARKIN R and PICHICHERO M. Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics. 1979;63:256-60. CrossrefMedlineGoogle Scholar29. BERG J. Neurologic complications of pertussis immunization. Br Med J. 1958;2:24-7. CrossrefMedlineGoogle Scholar30. . The prevention of whooping cough by vaccination: a Medical Research Council investigation. Br Med J. 1951;1:1463-71. CrossrefMedlineGoogle Scholar31. . Vaccination against whooping cough: relation between protection in children and results of laboratory tests. Br Med J. 1956;2:454-62. MedlineGoogle Scholar32. . Vaccination against whooping cough: a final report. Br Med J. 1959;1:994-1000. CrossrefMedlineGoogle Scholar33. . DTP vaccination and sudden infant deaths—Tennessee. Morbid Mortal Weekly Rep. 1979;28:131-2. Google Scholar34. CODY L, BARAFF L, and CHERRY J. The nature and rate of adverse reactions associated with DTP and DT immunization in infants and children. Pediatrics. In press. Google Scholar35. GORDON J and HOOD R. Whooping cough and its epidemiological anomalies. Am J Med Sci. 1951;222:333-61. CrossrefMedlineGoogle Scholar36. Joint Committees on Vaccination and Immunization of the Central Health Services Council. London: Her Majesty's Stationery Offices; 1977. Google Scholar37. KOPLAN J, SCHOENBAUM S, WEINSTEIN M, and FRASER D. Pertussis vaccine—an analysis of benefits, risks and costs. N Engl J Med. 1979;301:906-11. CrossrefMedlineGoogle Scholar38. KULENKAMPFF M, SCHWARTZMAN J, and WILSON J. Neurological complications of pertussis inoculation. Arch Dis Child. 1974;49:46-9. CrossrefMedlineGoogle Scholar39. LAMBERT H. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep. 1965;80:365-9. CrossrefMedlineGoogle Scholar40. MANCLARK C and HILL J eds. International Symposium on Pertussis, 3rd. Bethesda, Maryland: National Institutes of Health; 1978. (DHEW Publication no. (NIH) 79-1830.) Google Scholar41. MILLER D, ROSS E, ALDERSLADE R, BELLMAN M, and RAWSON N. Pertussis immunization and serious acute neurological illness in children. Br Med J. 1981;282:1595-9. CrossrefMedlineGoogle Scholar42. NELSON J. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child. 1978;132:371-3. CrossrefMedlineGoogle Scholar43. POLLARD R. Relation between vaccination and notification rates for whooping cough in England and Wales. Lancet. 1980;1:1180-2. CrossrefMedlineGoogle Scholar44. . Effect of a low pertussis vaccination uptake on a large community. Br Med J. 1981;282:23-6. CrossrefMedlineGoogle Scholar45. STROM J. Further experience of reactions especially of a cerebral nature in conjunction with triple vaccination: a study based on vaccinations in Sweden, 1959-1965. Br Med J. 1967;4:320-3. CrossrefMedlineGoogle Scholar46. VAN HEMERT P, VAN RAMSHORST J, and REGAMEY R, eds. International Symposium on Pertussis, 2nd. Bilthoven, The Netherlands 1969. Basel: S. Karger; 1970. (Symposia Series Immunobiological Standardization. Vol. 13.) Google Scholar47. WILKINS J, WILLIAMS F, WEHRLE P, and PORTNOY B. Agglutinin response to pertussis vaccine: I. Effect of dosage and interval. J Pediatr. 1971;79:197-202. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure Information▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHeavy Metal Antagonists and Miscellaneous DrugsDrug-induced ocular side effectsDrug-induced ocular side effectsThe immunogenicity and reactogenicity of Td booster vaccination in Korean preadolescents, aged with 11-12 years oldThe Need of Td Vaccination According to the Changes of Tetanus and Diphtheria ImmunityGuillain-Barré syndrome after combined tetanus-diphtheria toxoid vaccinationAcute radiculomyelitis after antitetanus vaccinationOptic neuritis and myelitis after booster tetanus toxoid vaccinationTreatment of Skin and Soft Tissue InfectionsHuman antibody response to fragments A and B of diphtheria toxin and a synthetic peptide of amino acid residues 141–157 of fragment ARapid evaluation of tetanus immunity by a haemagglutination test in the injured at a hospital emergency unitPet-Associated IllnessReações locais e níveis de antitoxina circulante decorrentes de administração do toxóide tetânico: estudo comparativo entre Ped-o-Jet e seringa hipodérmicaNaturally acquired immunity to tetanus toxin in an isolated communityManagement of Human and Animal Bite WoundsPrevalence of diphtheria carriers in a population with disappearing clinical diphtheriaHigh admission rate of infants and young children with whooping cough: clinical aspects and preventive implicationsWhooping cough vaccination: a review of the controversy since the 1981 DHSS report 1 December 1981Volume 95, Issue 6 Page: 723-728 Keywords Diphtheria Epidemiology Morbidity Mortality Pertussis Tetanus Vaccines ePublished: 1 December 2008 Issue Published: 1 December 1981 PDF downloadLoading ...